Innexus Nutraceuticals Launches Nutraceutical Palmitoylethanolamide (PEA)

GMP grade Palmitoylethanolamide – OptiPEA®

OptiPEA® Quality

“We have redefined PEA as an ingredient by producing in accordance with the high GMP production standards used in the pharmaceutical industry”  says Samuel Zonneveld, CEO, Innexus Nutraceuticals.

The problem with currently used PEA

Whether a brand name implies quality, purity or superiority, most, if not all of the PEA  commonly used in dietary supplement products, will be obtained from the Asian chemical industry. “I would not recommend to use any PEA products of which the quality and manufacturing data are unclear or not traceable”. 

About PEA

PEA is a nutraceutical that controls physiological mechanisms associated with chronic pain. It functions with more than one “modus operandi”. This “shot gun” effect is essential to making this molecule so effective for tackling the complexity of chronic pain.


OptiPEA® is now available as a bulk powder or as bulk capsules for companies that are looking to expand their product line. In Q1 of 2016 the first consumer products with OptiPEA® will be available in Europe. It is expected that the launch will have a big impact as the concerning issues with safety and quality are now resolved.

About Innexus Nutraceuticals

Innexus Nutraceuticals is a manufacturer of specialty nutraceuticals. They work with talented PhD chemists and experts in the nutritional field to develop and market exciting ingredients. We strive to produce the highest quality and make no concessions  with regard to  safety. Innexus Nutraceutical is headquartered in Nijmegen, The Netherlands. For more information see: www.innexusnutraceuticals.com.


Innexus Nutraceuticals B.V.
Public Relations:
+31 (0)85 3034209 | info@innexusnutraceuticals.com